Search bioRxiv⌕ Search

Biology subjects

Lau, T. T. Y.

Publications and source records attributed to Lau, T. T. Y..

3 recordsLinked to original sources

Enigma: An Efficient Model for Deciphering Regulatory Genomics

Genomic sequence-to-function models have emerged as powerful tools for deciphering cis-regulatory grammar to advance our understanding of disease biology and guide therapeutic development. Recent advances have been driven by multi-task training of large transformer-based models on thousands of genome tracks. However, these performance gains have come at significant computational cost for both training and inference, hindering large-scale applications and slowing future model development. Here, rather than continuing to scale model size and add more training tracks, we focus on architectural efficiency and train on a substantially smaller, curated set of genome tracks. Our model Enigma achieves competitive performance with current state-of-the-art models at single-base resolution while substantially reducing computational cost. On zero-shot variant effect prediction benchmarks, Enigma outperforms the leading open-source model, the Borzoi ensemble, while using 10.9% of its compute and improving resolution from 32 bases to a single base. Compared to AlphaGenome, Enigma achieves 90.4 - 97.3% of its performance using 7.5% of its estimated compute. These improvements in efficiency can facilitate further development of models for regulatory genomics. We demonstrate this by fine-tuning Enigma on predicting three new molecular phenotypes -- ChIP-seq, RNA half-life, and translation efficiency -- achieving or exceeding the performance of state-of-the-art task-specific models. We are providing Enigma for non-commercial use to benefit the broader research field. [Formula]Code: https://github.com/deepgenomics/enigma

genomics↗

CARD k-mers: Unmasking the pathogen hosts and genomic contexts of antimicrobial resistance genes in metagenomic sequences

Antimicrobial resistance (AMR) is a global health crisis requiring rapid surveillance across human, agricultural, and environmental systems. A major challenge during outbreaks is not only detecting antimicrobial resistance genes (ARGs), but also unmasking their pathogen hosts and genomic context, as ARGs alone do not fully capture AMR risk. Pathogen identification is often essential for guiding effective treatment. While culture-based methods remain the diagnostic gold standard, they are slow and sometimes impractical. Faster metagenomic (mNGS) tools typically detect either ARGs, taxonomy, or genomic context, but rarely all three, resulting in fragmented surveillance. Existing k-mer classifiers like Kraken2 and CLARK, designed for general taxonomy, often perform poorly on AMR-specific sequences. We introduce CARD k-mers, the first tool built to jointly predict species-level taxonomy and genomic context (plasmid vs. chromosome) for ARGs in short metagenomic reads. Integrated with the Comprehensive Antibiotic Resistance Database (CARD), CARD k-mers enables rapid, context-aware assignment of ARGs to their likely pathogen and genomic element origin. In benchmarking with 103,456 in-silico pathogen-specific AMR alleles, CARD k-mers outperformed Kraken2 and CLARK by 10.85% and 15.2%, respectively, and correctly classified the genomic context of 4,590 chromosome- and 176 plasmid-specific ARGs. The tool operates at speeds exceeding 675,000 metagenomic reads per minute. By delivering fast, accurate, and context-rich classification of ARGs, CARD k-mers significantly advances untargeted AMR surveillance and is accessible to users with basic command-line experience for use in both clinical and environmental pipelines. CARD k-mers is available at: https://github.com/arpcard/rgi.

bioinformatics↗

An RNA foundation model enables discovery of disease mechanisms and candidate therapeutics

Accurately modeling and predicting RNA biology has been a long-standing challenge, bearing significant clinical ramifications for variant interpretation and the formulation of tailored therapeutics. We describe a foundation model for RNA biology, "BigRNA", which was trained on thousands of genome-matched datasets to predict tissue-specific RNA expression, splicing, microRNA sites, and RNA binding protein specificity from DNA sequence. Unlike approaches that are restricted to missense variants, BigRNA can identify pathogenic non-coding variant effects across diverse mechanisms, including polyadenylation, exon skipping and intron retention. BigRNA accurately predicted the effects of steric blocking oligonucleotides (SBOs) on increasing the expression of 4 out of 4 genes, and on splicing for 18 out of 18 exons across 14 genes, including those involved in Wilson disease and spinal muscular atrophy. We anticipate that BigRNA and foundation models like it will have widespread applications in the field of personalized RNA therapeutics.

bioinformatics↗